Security key
14161Y200
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)
CUSIP: 14161Y200
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Class A Common Shares
- Total 13F shares
- 4,972,709
- Total 13F value
- $9,852,940
- Share change
- -403,335
- Put/Call ratio
- 183%
- SEC-reported price per share
- $1.98
- Number of holders
- 41
- Value change
- -$780,395
- Number of buys
- 16
- Number of sells
- 19
- Shares outstanding
- 117,675,173
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
41
Top holders
10
CRDL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Cardiol Therapeutics Inc. SEC filings
Cardiol Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14161Y200
Recent filing periods:
Ownership snapshot
Top reported holders of CRDL - Cardiol Therapeutics Inc. - Class A Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Tejara Capital Ltd
Disclosed value leader
Tejara Capital Ltd
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 1.5%
Showing 1-6 of 15 holder rows.
Quick read
Tejara Capital Ltd leads the comparable SEC ownership view at 1.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Tejara Capital Ltd's linked filing trail.
Comparable ownership
Top 5
Tejara Capital Ltd
1.5%
AdvisorShares Investments LLC
1.2%
MMCAP International Inc. SPC
0.79%
Lion Street Advisors, LLC
0.22%
Cambridge Investment Research Adv...
0.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Tejara Capital Ltd |
13F
Company
|
1.5%
|
$3,478,931
1,722,243 shares
|
— | 30 Jun 2024 |
| AdvisorShares Investments LLC |
13F
Company
|
1.2%
|
$2,933,944
1,466,972 shares
|
— | 30 Jun 2024 |
| MMCAP International Inc. SPC |
13F
Company
|
0.79%
|
$1,866,732
924,125 shares
|
— | 30 Jun 2024 |
| Lion Street Advisors, LLC |
13F
Company
|
0.22%
|
$505,377
253,281 shares
|
— | 30 Jun 2024 |
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
0.1%
|
$235,000
116,131 shares
|
— | 30 Jun 2024 |
| Knoll Capital Management, LLC |
13F
Company
|
0.08%
|
$202,000
100,000 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
41
Shares
4,972,709
Rows available
41
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
41
Q3 2024 holders
41
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend